RETHINKING ANDROGENETIC ALOPECIA: AN INTERNATIONAL EXPERT REVIEW PUBLISHED IN THE EUROPEAN JOURNAL OF DERMATOLOGY | L'Oréal Dermatological Beauty | L'Oréal Dermatological Beauty
- Mar 2026
Androgenetic alopecia (AGA) is the most prevalent form of hair loss worldwide, yet its biological complexity continues to evolve beyond traditional androgen-centric models. In a landmark expert review published in the European Journal of Dermatology, global specialists consolidate more than two decades of scientific evidence to redefine AGA as a multifactorial disorder driven by hormonal, inflammatory, structural and ageing-related mechanisms. This integrative perspective reframes hair loss not as an isolated follicular event, but as the result of progressive ecosystem dysfunction involving the follicle, dermal matrix and scalp microenvironment.
BEYOND HORMONES: A MULTIFACTORIAL PATHOPHYSIOLOGY
The publication details how androgen sensitivity interacts with oxidative stress, genetic predisposition and chronic microinflammation to progressively alter follicular cycling. Over time, anagen phases shorten while telogen shedding increases, leading to visible reductions in density and fibre thickness. Importantly, follicular miniaturization is presented not merely as a hormonal consequence but as the endpoint of cumulative biological stressors affecting stem cell activity and dermal papilla signaling.
MICROINFLAMMATION AND PERIFOLLICULAR FIBROSIS
One of the most compelling insights explored is the structural remodeling of the perifollicular environment. Progressive collagen rigidification surrounding the follicle reduces vascular supply, oxygen diffusion and nutrient delivery. Histological observations presented in the review highlight how this fibrosis weakens follicular anchorage and contributes to accelerated shedding. This extracellular matrix stiffening also impairs the follicle’s regenerative capacity.
PSYCHOSOCIAL BURDEN OF HAIR LOSS
Beyond biological mechanisms, the review dedicates significant focus to the emotional and psychological burden of AGA. Clinical studies cited in the paper show measurable impacts on self-esteem, social engagement and quality of life — particularly among women.
This dimension reinforces the importance of early diagnosis and comprehensive management strategies that address both visible symptoms and patient well-being.
TOWARD INTEGRATIVE THERAPEUTIC STRATEGIES
The review concludes by emphasizing the need for multidimensional management. While pharmacologic therapies remain foundational, emerging approaches target extracellular matrix flexibility, follicular metabolism and regenerative signalling pathways.
By addressing intra- and extra-follicular drivers simultaneously, these strategies aim to preserve follicular function over time rather than merely delay hair loss progression.